• Home
  • HER2 Testing Service

HER 2 Testing Service

We perform over 2000 HER2 Immunohistochemistry and 800 FISH tests per year, on breast cancer cases, using FDA approved and validated assays ( Pathway 4B5 antibody from Roche/Ventana and PathVysion dual colour FISH probe from Abbott Molecular (both CE marked)
All testing is performed in accordance with National Guidelines.

References:

  • Bartlett JMS, Starczynski J et al. HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods. J Clin Pathol 2011; 64: 649-653)
  • Woolff AC, Hammond EH et al. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor 2 Testing in Breast Cancer. J Clin Oncol 2007; 25 (1): 118-145
  • Walker RA, Bartlett JMS et al. HER2 testing in the UK: further update to recommendations. J Clin Pathol 2008; 61: 818-824
  • Ellis IO, Dowsett M et al. Recommendations for HER2 testing in the UK. J Clin Pathol 2000; 53: 890-2
  • Ellis IO, Bartlett J et al. Updated recommendations for HER2 testing in the UK. J Clin Pathol 2004; 57: 233-7)

We are a national reference centre laboratory for HER2 testing
We participate in national UKNEQAS scheme for HER2 testing
We are actively involved in monitoring and auditing all aspects of the HER2 service to best meet the need of our users.

Read more: HER 2 Testing Service

  • Created on .
  • Last updated on .

Copyright heftpathology 2013, 2014, 2015, 2016, 2017, 2018

HTA licence number is 12366

Protection of Personal Information – Laboratory Medicine comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.

The Trust Laboratories at Heartlands Hospital, Good Hope Hospital and Solihull Hospital were awarded UKAS (United Kingdom Accreditation Service) accreditation to the internationally recognised ISO 15189 standard in May 2015. For a list of accredited tests and other information please visit the test database http://www.heftpathology.com/frontpage/test-database.html.
Tests not appearing on this scope are either under consideration or in the process of accreditation and so currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.

For further information contact Louise Fallon, Quality Manager, 0121 424 1235

UKAS Logos